Evaluation of stigma toward individuals with acne
JAMA Dermatology
2023-12-06
(Press-News.org)
About The Study: This survey study with 1,357 respondents demonstrates that stigmatizing attitudes toward patients with acne existed across a variety of social and professional scenarios, with severe acne and acne in darker skin tone being associated with a greater degree of stigma. These findings highlight the need to identify approaches to reduce stigmatizing attitudes in the community and for adequate access to care, which might prevent negative downstream effects related to these stigmatizing attitudes.
Authors: John S. Barbieri, M.D., M.B.A., of Brigham and Women’s Hospital in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamadermatol.2023.4487)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2023.4487?guestAccessKey=39c38e87-cb87-4f98-a6af-ea7cacac8823&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120623
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-12-06
About The Study: This randomized clinical trial found that a single health care worker-collected throat specimen had higher sensitivity for rapid antigen testing for SARS-CoV-2 than a nasal specimen. In contrast, the self-collected nasal specimens had higher sensitivity than throat specimens for symptomatic participants. Adding a throat specimen to the standard practice of collecting a single nasal specimen could improve sensitivity for rapid antigen testing in health care and home-based settings.
Authors: Tobias Todsen, M.D., Ph.D., of Copenhagen University Hospital in ...
2023-12-06
Human fingers and toes do not grow outward; instead, they form from within a larger foundational bud, as intervening cells recede to reveal the digits beneath. This is among many processes captured for the first time as scientists unveil a spatial cell atlas of the entire developing human limb, resolved in space and time.
Researchers at the Wellcome Sanger Institute, Sun Yat-sen University, EMBL’s European Bioinformatics Institute and collaborators applied cutting-edge single-cell and spatial technologies to create an atlas characterising the cellular landscape of the early human limb, pinpointing the exact ...
2023-12-06
Like any typical car or house or society, the pace at which parts of our bodies fall apart varies from part to part.
A study of 5,678 people, led by Stanford Medicine investigators, has shown that our organs age at different rates — and when an organ’s age is especially advanced in comparison with its counterpart in other people of the same age, the person carrying it is at heightened risk both for diseases associated with that organ and for dying.
According to the study, about 1 in every 5 reasonably ...
2023-12-06
A central goal in quantum optics and photonics is to increase the strength of the interaction between light and matter to produce, e.g., better photodetectors or quantum light sources. The best way to do that is to use optical resonators that store light for a long time, making it interact more strongly with matter. If the resonator is also very small, such that light is squeezed into a tiny region of space, the interaction is enhanced even further. The ideal resonator would store light for a long time in a region at the size of a single atom.
Physicists and engineers have struggled for decades with how ...
2023-12-06
Research led by Queen Mary University of London’s Wolfson Institute of Population Health has found that hormone levels, measured through blood tests, are an important indicator of whether women will benefit from recently licensed medication for the prevention of breast cancer.
Aromatase inhibitors such as anastrozole are recommended by the National Institute of Clinical Care and Excellence (NICE) as an option for preventive therapy in post-menopausal women at high risk of breast cancer. Anastrozole (Arimidex) is now also licensed by the ...
2023-12-06
ABSTRACTS: 162, 309, 322, 364, 741, 774, 856, 983
SAN DIEGO ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
This special edition features oral presentations from the 2023 American Society of Hematology (ASH) Annual Meeting, describing the latest scientific and clinical breakthroughs for hematological cancers. In addition to these ...
2023-12-06
INDIANAPOLIS – As hospitalizations due to chronic conditions increase across the United States, attention is focusing on using data collected in electronic health records (EHRs) by healthcare systems to enable public health departments to gain understanding of the incidence and prevalence of hypertension, diabetes, asthma, obesity and other chronic diseases with the ultimate goal of improving disease outcomes.
In the U.S., 90 percent of clinicians, medical laboratories, imaging centers and other providers use EHR systems, providing ample data on individuals with access to healthcare. However, access ...
2023-12-06
SAN ANTONIO – A combination of two HER2-targeted drugs, tucatinib (Tukysa) and trastuzumab emtansine (Kadcyla, T-DM1), extended progression-free survival among patients with unresectable locally advanced or metastatic HER2-positive breast cancer, compared with T-DM1 alone, according to results from the HER2CLIMB-02 trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.
T-DM1 is an antibody-drug conjugate comprised of trastuzumab (Herceptin) and the cytotoxic drug emtansine. It was approved for use ...
2023-12-06
SAN ANTONIO – For patients whose breast cancer converted from lymph node-positive to lymph node-negative disease after neoadjuvant chemotherapy, skipping adjuvant regional nodal irradiation (RNI) did not increase the risk of disease recurrence or death five years after surgery, according to results from the NRG Oncology/NSABP B-51/RTOG 1304 clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.
Patients who are diagnosed with breast cancer that has already spread to regional lymph nodes may receive neoadjuvant chemotherapy; in some cases, neoadjuvant therapy completely eradicates ...
2023-12-06
Washington, December 6, 2023—Students achieve better grades in college science, technology, engineering, and math (STEM) courses when those classrooms have higher numbers of underrepresented racial-minority and first-generation college students, according to new research released today. The findings were published in AERA Open, a peer-reviewed journal of the American Educational Research Association.
While this link holds true for all students, it is even stronger for students who are underrepresented racial minorities (URMs) and the first in their family to attend college. The authors found that in STEM courses ...
LAST 30 PRESS RELEASES:
[Press-News.org] Evaluation of stigma toward individuals with acne
JAMA Dermatology
